Success factors for foreign players entering the Swiss pharmaceuticals market
- Michael Zürcher
- Mar 19
- 1 min read
An interview with Margarida Duarte, Executive Vice President and Chief Commercial Officer at Deciphera Pharmaceuticals
Switzerland's life sciences ecosystem enjoys an international reputation as an attractive location for biotech and pharma companies looking to establish a strong European presence. Michael Zürcher, CEO and owner of Swizzard, asked Margarida Duarte, Executive Vice President and Chief Commercial Officer at Deciphera Pharmaceuticals, what makes Switzerland such an attractive hub and how biotech companies can prepare for success when setting up the business in Switzerland.
Read and download the exclusive interview in its full length by clicking on the button below.
About Swizzard
Swizzard Pharma AG supports biotech and pharma companies in successfully entering and thriving in the Swiss market. Committed to bringing innovation to Switzerland, Swizzard helps clients maximize the value of their medical breakthroughs through expert market entry, preparation, commercialization and access strategies. With deep industry expertise, hands-on experience and an extensive network, Swizzard delivers fast, efficient, and tailored solutions. The company is led by CEO Michael Zürcher, a seasoned life sciences executive with a strong track record in the industry.
Comments